V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 230000369 | 230000214 | 1.82 | 78 | Palliative (P) | null | 2014-04-15 | Capecitabine | N | N | 230002257 | OXALIPLATIN + MDG |
| 230000370 | 230000215 | 1.77 | 84 | Adjuvant (A) | 2015-04-09 | 2015-04-23 | Sorafenib | 02 | null | 230002292 | CAPECITABINE |
| 230000371 | 230000216 | 1.67 | 86.7 | Palliative (P) | 2017-10-08 | 2017-10-14 | CAPECITABINE + OXALIPLATIN | N | N | 230002302 | FLUOROURACIL |
| 230000372 | 230001131 | 1.7 | 80 | Palliative (P) | 2015-02-08 | 2015-03-05 | Capecitabine | N | N | 230002394 | CAPECITABINE |
| 230000373 | 230001131 | 1.6 | 73.1 | Adjuvant (A) | 2014-03-24 | 2014-05-11 | FLUOROURACIL | N | N | 230002394 | CAPECITABINE + OXALIPLATIN |
| 230000374 | 230000217 | 1.75 | 80 | Palliative (P) | 2008-07-25 | 2013-04-28 | CHOP R - 21 days | 02 | Y | 230002469 | OXALIPLATIN + MDG |
| 230000375 | 230000217 | 1.51 | 67.4 | Palliative (P) | 2017-12-19 | 2017-12-28 | CAPECITABINE + RT | N | N | 230002469 | CAPECITABINE + RT |
| 230000376 | 230000218 | 1.72 | 73.8 | null | 2014-09-17 | 2014-09-20 | Capecitabine | N | null | 230002528 | FLUOROURACIL |
| 230000377 | 230001133 | 1.73 | 77.5 | Curative (C) | 2015-02-04 | 2015-02-04 | Capecitabine 35days + RT | 02 | Y | 230002573 | CAPECITABINE |
| 230000378 | 230000219 | 1.72 | 117 | Adjuvant (A) | 2015-08-10 | 2015-08-10 | CISPLATIN + DOCETAXEL + FLUOROURACIL | 2 | N | 230002574 | BEVACIZUMAB + CAPECITABINE |
| 230000379 | 230000219 | 1.65 | 67.4 | Adjuvant (A) | 2012-06-14 | 2012-06-14 | Cisplatin + Radiotherapy + CISPLATIN | 02 | N | 230002574 | CAP + RT |
| 230000380 | 230000219 | 1.67 | 54.8 | Palliative (P) | 2017-08-01 | 2017-08-22 | Trastuzumab Subcutaneous | N | null | 230002574 | CAPECITABINE + OXALIPLATIN |
| 230000381 | 230000219 | 1.52 | 69 | Curative (C) | 2016-08-01 | 2016-08-01 | Capecitabine + Oxaliplatin 14day | 02 | Y | 230002574 | IRINOTECAN + MDG |
| 230000382 | 230000219 | 1.61 | null | null | 2015-02-12 | 2015-02-19 | Sorafenib | N | null | 230002574 | BENDAMUSTINE + RITUXIMAB |
| 230000383 | 230000219 | 1.49 | null | Adjuvant (A) | 2016-04-12 | 2016-04-30 | Sorafenib | N | N | 230002574 | CAPECITABINE + RT |
| 230000384 | 230000220 | 1.65 | 100.55 | Adjuvant (A) | 2018-07-22 | 2018-08-04 | Oxaliplatin + Modified de Gramont | N | N | 230002628 | FLUOROURACIL |
| 230000385 | 230000221 | null | 52.5 | Palliative (P) | 2018-03-30 | 2018-03-30 | TEMOZOLOMIDE | N | N | 230002637 | CAPECITABINE + OXALIPLATIN |
| 230000386 | 230000222 | 1.76 | null | Not known (9) | 2017-12-17 | 2018-01-09 | CAPECITABINE + OXALIPLATIN | N | N | 230002652 | CAPECITABINE + OXALIPLATIN |
| 230000387 | 230001135 | 1.49 | null | Curative (C) | 2014-05-26 | 2014-05-28 | Capecitabine 35days + RT | N | null | 230002682 | CAPECITABINE + OXALIPLATIN |
| 230000388 | 230001135 | 1.61 | 70.4 | Palliative (P) | 2018-04-13 | 2018-04-13 | Capecitabine + Mitomycin | 02 | N | 230002682 | CAPECITABINE |
| 230000389 | 230001135 | 1.7 | 86.4 | Palliative (P) | 2016-02-23 | 2016-03-01 | CAPECITABINE + OXALIPLATIN | N | N | 230002682 | CAPECITABINE |
| 230000390 | 230001706 | 1.67 | 79.5 | Curative (C) | 2017-03-28 | 2017-03-28 | CAPECITABINE + MITOMYCIN + RT | 02 | N | 230002723 | CAPECITABINE |
| 230000391 | 230001734 | 1.74 | 82.2 | Palliative (P) | 2015-09-04 | 2015-09-10 | GEMCITABINE | N | N | 230002727 | OXALIPLATIN + MDG |
| 230000392 | 230000223 | 1.75 | 68.5 | Adjuvant (A) | 2016-04-06 | 2016-04-10 | FEC + DOCETAXEL | N | N | 230002741 | CISPLATIN + GEMCITABINE |
| 230000393 | 230000224 | 0 | 66.6 | null | 2018-09-16 | 2018-09-16 | FLUOROURACIL + MITOMYCIN + RT | N | null | 230002744 | CAPECITABINE + OXALIPLATIN |
| 230000394 | 230000225 | null | null | Adjuvant (A) | 2014-08-15 | 2014-08-24 | Fluorouracil + Folinic Acid Weekly | N | N | 230002746 | CAPECITABINE |
| 230000395 | 230000226 | 1.67 | 97 | null | 2015-10-15 | 2015-10-31 | Cisplatin + Vinorelbine (IV) | N | null | 230002770 | CAPECITABINE + OXALIPLATIN |
| 230000396 | 230000227 | 1.6 | 71.5 | Neo-adjuvant (N) | 2017-08-14 | 2017-09-01 | Carboplatin + Etoposide IV 3 day | N | N | 230002819 | CAPECITABINE + RT |
| 230000397 | 230000227 | null | 70.6 | Disease modification (D) | 2015-10-13 | 2015-10-26 | Capecitabine 35days + RT | 02 | N | 230002819 | CAPECITABINE + OXALIPLATIN |
| 230000398 | 230000228 | 1.66 | 69.3 | Adjuvant (A) | 2014-05-13 | 2014-05-19 | MPT | 2 | N | 230002842 | CAPECITABINE |
| 230000399 | 230000229 | 1.68 | null | Adjuvant (A) | 2017-08-03 | 2017-08-30 | Capecitabine | N | null | 230002844 | CAPECITABINE + OXALIPLATIN |
| 230000400 | 230000230 | 1.7 | null | Neo-adjuvant (N) | 2014-05-04 | 2014-05-04 | CVP R | 02 | N | 230002870 | CVP R |
| 230000401 | 230000231 | 1.56 | 84 | Palliative (P) | 2018-02-03 | 2018-03-01 | Fluorouracil + Folinic Acid Weekly | 02 | N | 230002936 | BENDAMUSTINE + RITUXIMAB |
| 230000402 | 230000231 | 1.6 | 72.4 | Not known (9) | null | 2016-10-03 | CAPECITABINE + OXALIPLATIN | null | null | 230002936 | OXALIPLATIN + MDG |
| 230000403 | 230000232 | 1.71 | 82.2 | Curative (C) | 2014-02-15 | 2014-04-14 | Gemcitabine weekly | N | N | 230003007 | CAPECITABINE + OXALIPLATIN |
| 230000404 | 230000232 | 1.61 | null | Palliative (P) | 2015-10-25 | 2015-11-09 | Sorafenib | N | N | 230003007 | FEC |
| 230000405 | 230000233 | 1.64 | 69.3 | Curative (C) | 2013-08-04 | 2013-08-17 | FLUOROURACIL | 2 | Y | 230003082 | OXALIPLATIN + MDG |
| 230000406 | 230000233 | 1.72 | null | Curative (C) | 2013-10-14 | 2013-10-26 | Fluorouracil+Mitomycin+RT (Anal Ca) | N | N | 230003082 | BEVACIZUMAB + CAPE + OXALIPLATIN |
| 230000407 | 230000234 | 1.66 | 77.9 | Palliative (P) | 2016-03-23 | 2016-03-27 | AFATINIB | N | N | 230003112 | CAPECITABINE + OXALIPLATIN |
| 230000408 | 230000235 | 1.7 | 74.3 | Curative (C) | 2014-09-30 | 2014-09-30 | R GCVP | N | N | 230003118 | CAPECITABINE + OXALIPLATIN |
| 230000409 | 230000236 | 1.6 | 61 | Palliative (P) | 2017-04-05 | 2017-04-12 | Fluorouricil + Folonic Acid (MdG) | 02 | N | 230003139 | CAPECITABINE + RT |
| 230000410 | 230000237 | 1.68 | 59.7 | Curative (C) | 2015-04-04 | 2015-04-07 | Capecitabine | N | N | 230003151 | FLUOROURACIL |
| 230000411 | 230000238 | 0 | 53 | Palliative (P) | 2014-07-20 | 2014-07-20 | Oxaliplatin + Modified de Gramont | 02 | N | 230003200 | ERIBULIN |
| 230000412 | 230000239 | null | null | Adjuvant (A) | null | 2016-12-20 | Fluorouracil + Folinic Acid Weekly | null | N | 230003211 | CAPECITABINE |
| 230000413 | 230000240 | null | 54 | Curative (C) | 2018-01-02 | 2018-01-02 | Capecitabine 35days + RT | null | null | 230003220 | CAPECITABINE + OXALIPLATIN |
| 230000414 | 230000241 | 1.73 | 87 | Adjuvant (A) | 2012-07-11 | 2014-01-18 | CAPECITABINE + OXALIPLATIN | N | N | 230003228 | CAPECITABINE + OXALIPLATIN |
| 230000415 | 230000242 | 1.77 | 72.8 | Palliative (P) | 2014-06-09 | 2014-06-18 | Oxaliplatin + Modified de Gramont | 02 | N | 230003237 | CAPECITABINE + RT |
| 230000416 | 230001140 | 1.74 | 92 | Curative (C) | 2018-08-15 | 2018-08-17 | Capecitabine + Oxaliplatin 21day | 02 | N | 230003246 | PANITUMUMAB |
| 230000417 | 230000243 | 1.71 | 61.5 | Curative (C) | 2013-09-23 | 2013-10-15 | Oxaliplatin + Modified de Gramont | 02 | N | 230003267 | OXALIPLATIN + MDG |
| 230000418 | 230000243 | 1.82 | 0 | Adjuvant (A) | 2014-05-24 | 2014-05-25 | Bendamustine+Rituximab(Sub Courses) | N | N | 230003267 | CAPECITABINE + OXALIPLATIN |